Professional Documents
Culture Documents
a b
Department of Nutrition – Gillings School of Global Public Health, Department of Exercise and Sport Science,
and c Human Movement Science Curriculum, University of North Carolina, Chapel Hill, N.C., USA
Abstract
This chapter addresses what is known about the endocrine system components growth hormone
(GH)-insulin-like growth factor (IGF) axis, thyroid axis, and prolactin relative to exercise and exercise
training. Each one of these hormone axes contributes to the maintenance of homeostasis in the body
through impact on a multitude of physiological systems. The homeostatic disruption of exercise
causes differing responses in each hormone axis. GH levels increase with sufficient stimulation, and
IGFs are released in response to GH from the anterior pituitary providing multiple roles including
anabolic properties. Changes in the thyroid hormones T3 and T4 vary greatly with exercise, from in-
creases/decreases to no change in levels across different exercise types, intensities and durations.
These ambiguous findings could be due to numerous confounding factors (e.g. nutrition status)
within the research. Prolactin increases proportionally to the intensity of the exercise. The magnitude
may be augmented with extended durations; conflicting findings have been reported with resistance
training. While the responses to exercise vary, it appears there may be overall adaptive and regen-
erative impacts on the body into recovery by these hormones through immune and tissue inflam-
matory responses/mediations. Nonetheless, well-designed exercise research studies are still needed
on each of these hormones, especially thyroid hormones and prolactin. © 2016 S. Karger AG, Basel
The endocrine system consists of a series of glandular tissues located throughout the
human body, which secrete hormones to serve as chemical messengers that can mod-
ify and regulate the physiological function of tissues. Numerous hormones not only
have such ‘endocrine-like’ effects, but also have ‘autocrine’ and ‘paracrine’ functions,
which collectively allow for these substances to have far-reaching and powerful phys-
iological effects. Additionally, recent discoveries point to many nonglandular tissues
in the human body that secrete hormones and hormone-like substances (e.g. cyto-
kines from skeletal muscles).
144.82.108.120 - 6/29/2016 1:55:01 PM
Downloaded by:
UCL
Such discoveries have added to the complexity of trying to understand the endo-
crine-hormone interactive controls involved when the homeostasis of the body is
challenged. A potent disruptor to the homeostasis of the body is physical exercise and
exercise training. Numerous research studies have quantified the dynamic and robust
hormonal responses to exercise activities, whether these activities involve cardiovas-
cular function for prolonged periods (endurance) or skeletal muscle strength-power
in an explosive nature (resistance).
The purpose of this article is to provide a concise discussion on the current under-
standing of the roles of the pituitary hormones prolactin and growth hormone (GH),
the insulin-like growth factor (IGF)-GH axis, and the thyroid axis with respect to
physical exercise and exercise training. Contemporary endocrinology research points
to interactive roles for the specific hormones associated with these axes and glands,
which play key physiological roles with respect to effects on the ability to do physical
exercise and the adaptation process following exercise training.
GH is a family of hormones with over 100 variants in isoform and aggregate combi-
nations [1, 2]. The isoform that is most common and typically measured in most ex-
ercise studies is the 191-amino acid (22-kDa) variant. This 22-kDa form will be the
focus of this discussion here within when referring to GH. The specific role of each
variant (isoform or aggregate) is yet to be fully determined as far more research is
needed, but exercise does appear to be an effective stimulator for the production and
release of many of these variants, i.e. acute increases can be observed following single
exercise bouts as well as chronic elevations in response to select exercise training pro-
grams [3].
Regulation
Relative to regulation, in response to an exercise bout, GH-releasing hormone
(GHRH) is secreted from the hypothalamus. GHRH travels along the hypophyseal
portal vascular system to the anterior pituitary where GHRH receptor activation re-
sults in GH production/release from the somatotropic cells of the pituitary. In con-
trast, inhibition of GH production occurs due to the release of somatostatin (GH-
inhibiting hormone). The key factors that influence the release of GHRH and GH-
inhibiting hormone in this complex system are depicted in figure 1.
Exercise Effects
Increased circulation of GH is observed with exercise provided the amount of muscle
mass recruited is great enough or there is a sufficient metabolic need [4, 5]. Further-
more, GH is very sensitive to changes in pH, as illustrated by a general direct relation-
ship between blood lactate and GH with exercise [1]. For this latter reason, exercise
144.82.108.120 - 6/29/2016 1:55:01 PM
+
+
Somatostatin GHRH
Arginine
Dopamine
Serotonin
Acetylcholine
Ghrelin
– +
–
Pituitary
gland Ghrelin
Thyroid hormones
Glucocorticoids
+
GH
sessions with protocols that challenge the acid-base/pH status (i.e. short rest-work
cycles) can provoke dramatic GH increases [6–8].
Once released in the circulation, GH can exhibit pleiotropic effects, and it can play
key roles in promoting increased lipid metabolism, chronological growth, reproduc-
tion, and immune and neural functions. Relative to endurance exercise and energy
metabolism, the role of GH in lipid metabolism can be especially critical [1, 2]. In the
context of exercise training (primarily strength or resistance based), GH also plays an
important role in muscular development by select direct anabolic effects as well as by
mediating circulating or locally produced IGF [9, 10].
Thyroid Axis
The thyroid is a critical endocrine gland in the human body. It produces and secretes
three hormones: thyroxine [T4 (3,5,3′,5′-tetraiodothyronine)], triiodothyronine [T3
(3,5,3′-triiodothyronine)] and calcitonin. Both T3 and T4 are considered critical for
the normal physiological function of a broad spectrum of tissues and organs due to
their ability to modulate metabolism, and act synergistically with other hormones (i.e.
144.82.108.120 - 6/29/2016 1:55:01 PM
Regulation
The production and secretion of the thyroids is controlled by thyroid-stimulating
hormone (TSH; also called thyrotropin), a glycoprotein-based hormone released
from the adenohypophysis (anterior pituitary). Thyroid-releasing hormone (TRH)
produced by the hypothalamus stimulates the release of TSH. The control and release
of these hormones involve a negative feedback loop referred to as the hypothalamic-
pituitary-thyroidal axis [23].
Once in the circulation, these hormones exist in a bound as well as in a free, un-
bound form. The carrier proteins for the bound forms of the hormones are thyroid-
binding globulin (accounting for 70%), thyroxine-binding pre-albumin (10–15%),
and albumin (15–20%). The unbound free forms of the hormones are a relatively
small amount of each hormone’s respective total amounts (free T4 ∼0.03% and free
T3 ∼0.3%). These free forms are the most effective and biologically active versions of
each hormone.
Circulating concentrations of T4 exceed that of T3, but T3 is the more biologically
potent of the hormones. The turnover rate of the thyroids is very low relative to their
existing large extracellular hormonal pool. This fact can make it complex and chal-
lenging for researchers to detect hormonal changes, even relatively large ones, in thy-
roid gland activity following a disruption in homeostasis [23].
Most tissues are strongly influenced metabolically by the thyroids, and these hor-
monal changes can profoundly influence many tissue functions, growth, and develop-
ment across the human age span [23–25]. As an illustration, thyroids increase oxida-
tive phosphorylation in mitochondria and responsiveness to catecholamines (which
can influence metabolic rate), and have a cardiogenic effect. A similar synergetic effect
occurs for GH. The thyroids can augment all aspects of lipid metabolism in the body,
especially within skeletal muscles. They also enhance hepatic glycogenolysis and in-
fluence protein degradation.
Exercise Effects
Short-term incremental exercise (<20 min) elevates TSH concentrations, with a criti-
cal intensity [oxygen uptake (VO2max)] threshold of approximately 50% of VO2max
being necessary to induce significant changes in the concentration [25, 26]. Even
though TSH is elevated, most research on such short-term exercise indicates the con-
centrations of total and free T4 and T3 are not affected [25]. Reports of increases in
total levels of thyroids during the recovery from such exercise exist; however, these
findings appear to be the function of exercise hemoconcentration of the blood. An
increase in TSH levels might be expected to stimulate the thyroid gland, but
144.82.108.120 - 6/29/2016 1:55:01 PM
Prolactin
The hormone prolactin is primarily produced and secreted by lactotrope cells of the
anterior pituitary, but there are also extrapituitary sources of the hormone – the
breast, decidua, adipose tissue, parts of the central nervous system, and select immune
system cells. Since it is released by extrapituitary sites, it is not only classified as a cir-
culating hormone but also as an autocrine and paracrine factor. Many tissues within
humans express prolactin receptors as it is a multifunctional hormone. For example,
its release and subsequent function has been linked to emotional-physical stress, wa-
ter balance regulation, fetal surfactant development, immune system activation, and
reproductive function. Most published research on prolactin relates to this last topic
because prolactin has long been associated with lactogenesis in women and gonadal
suppression (at excessive circulating levels) in both men and women.
Regulation
In the circulation, prolactin displays a diurnal secretion pattern with peak levels dur-
ing REM sleep at night [40]. There are a multitude of external and internal stimuli that
influence hypothalamic neurons to secrete prolactin-releasing (PRFs) and -inhibiting
factors (PIFs). PIFs or PRFs in turn affect the lactotrope cell production of prolactin.
Prolactin is secreted in episodes, which is under inhibitory control exerted by dopa-
mine as the main PIF. Stimulatory mechanisms for prolactin secretion result from the
disinhibition of dopamine activity or superimposition of stimulatory input through
one or more PRFs. There are several PRFs, including TRH, arginine vasopressin, va-
soactive intestinal peptide, oxytocin, estrogen, pituitary adenylate cyclase-activating
polypeptide, endogenous opioids, bradykinin, and substance P [40, 41].
Exercise Effects
Circulating prolactin concentrations increase with exercise, and the magnitude of the
increase is approximately proportional to the intensity of the exercise activity. Wheth-
er there is a critical intensity threshold necessary to induce a hormonal response is
144.82.108.120 - 6/29/2016 1:55:01 PM
The GH-IGF, thyroids, and prolactin are interconnected, as they share certain as-
pects of regulation in common. A prime example of this is the fact that an increase
in TRH release from the hypothalamus is not only a stimulant to the release of TSH,
but also to the release of pituitary GH and prolactin. In addition, sex steroids (e.g.
estrogens) provide a regulatory link by also exerting a positive effect on GH, thy-
roids, and prolactin. Likewise, ‘stressful’ situations can result in TRH/TSH release
as well as GH and prolactin release proportional to the magnitude of the stress [24,
40, 54].
Functionally, these hormonal interrelated responses during exercise can provide a
multitude of beneficial physiological effects. For example, GH, IGFs, thyroids, and
prolactin can be described, in general, as immune-permissive and immune-regulatory
144.82.108.120 - 6/29/2016 1:55:01 PM
References
1 Baumann G: Growth hormone heterogeneity: genes, 9 Sotiropoulos A, Ohanna M, Kedzia C, Menon RK,
isohormones, variants, and binding proteins. En- Kopchick JJ, Kelly PA, Pende M: Growth hormone
docr Rev 1991;12:424–449. promotes skeletal muscle cell fusion independent of
2 Kraemer WJ, Dunn-Lewis C, Comstock BA, Thomas insulin-like growth factor 1 up-regulation. Proc Natl
GA, Clark JE, Nindl BC: Growth hormone, exercise, Acad Sci USA 2006;103:7315–7320.
and athletic performance: a continued evolution of 10 Perrini S, Laviola L, Carreira MC, Cignarelli A, Na-
complexity. Curr Sports Med Rep 2010;9:242–252. talicchio A, Giorgino F: The GH/IGF1 axis and sig-
3 Kraemer WJ, Nindl BC, Marx JO, Gotshalk LA, Bush naling pathways in the muscle and bone: mecha-
JA, Welsch JR, Volek JS, Spiering BA, Maresh CM, nisms underlying age-related skeletal muscle wasting
Mastro AM, Hymer WC: Chronic resistance train- and osteoporosis. J Endocrinol 2010;205:201–210.
ing in women potentiates growth hormone in vivo 11 Nindl BC, Pierce JR: Insulin-like growth factor I as a
bioactivity: characterization of molecular mass vari- biomarker of health, fitness, and training status. Med
ants. Am J Physiol Endocrinol Metab 2006; 291: Sci Sports Exerc 2010;42:39–49.
E1177–E1187. 12 Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R,
4 Milner-Brown HS, Stein RB, Yemm R: The orderly Costantino A, Goldfine ID, Belfiore A, Vigneri R: In-
recruitment of human motor units during voluntary sulin receptor isoform A, a newly recognized, high-
isometric contractions. J Physiol 1973;230:359–370. affinity insulin-like growth factor II receptor in fetal
5 French DN, Kraemer WJ, Volek JS, Spiering BA, Ju- and cancer cells. Mol Cell Biol 1999;19:3278–3288.
delson DA, Hoffman JR, Maresh CM: Anticipatory 13 Kraemer WJ, Marchitelli L, Gordon SE, Harman E,
responses of catecholamines on muscle force pro- Dziados JE, Mello R, Frykman P, McCurry D, Fleck
duction. J Appl Physiol 2007;102:94–102. SJ: Hormonal and growth factor responses to heavy
6 Kraemer WJ, Fleck SJ, Dziados JE, Harman EA, resistance exercise protocols. J Appl Physiol 1990;69:
Marchitelli LJ, Gordon SE, Mello R, Frykman PN, 1442–1450.
Koziris LP, Triplett NT: Changes in hormonal con- 14 Kraemer WJ, Gordon SE, Fleck SJ, Marchitelli LJ,
centrations after different heavy-resistance exercise Mello R, Dziados JE, Friedl K, Harman E, Maresh C,
protocols in women. J Appl Physiol 1993; 75: 594– Fry AC: Endogenous anabolic hormonal and growth
604. factor responses to heavy resistance exercise in males
7 Kraemer WJ, Marchitelli L, Gordon SE, Harman E, and females. Int J Sports Med 1991;12:228–235.
Dziados JE, Mello R, Frykman P, McCurry D, Fleck 15 Rubin MR, Kraemer WJ, Maresh CM, Volek JS,
SJ: Hormonal and growth factor responses to heavy Ratamess NA, Vanheest JL, Silvestre R, French DN,
resistance exercise protocols. J Appl Physiol 1990;69: Sharman MJ, Judelson DA, Gomez AL, Vescovi JD,
1442–1450. Hymer WC: High-affinity growth hormone binding
8 Hymer WC, Kraemer WJ, Nindl BC, Marx JO, Ben- protein and acute heavy resistance exercise. Med Sci
son DE, Welsch JR, Mazzetti SA, Volek JS, Deaver Sports Exerc 2005;37:395–403.
DR: Characteristics of circulating growth hormone 16 Nindl BC, Pierce JR: Insulin-like growth factor I as a
in women after acute heavy resistance exercise. Am J biomarker of health, fitness, and training status. Med
Physiol Endocrinol Metab 2001;281:E878–E887. Sci Sports Exerc 2010;42:39–49.
17 Nindl BC, Alemany JA, Tuckow AP, Kellogg MD,
Sharp MA, Patton JF: Effects of exercise mode and
duration on 24-h IGF-I system recovery responses.
Med Sci Sports Exerc 2009;41:1261–1270.
144.82.108.120 - 6/29/2016 1:55:01 PM
1989;23:194.
E-Mail ach@email.unc.edu